Harvard Bioscience Inc
HBIO· Nasdaq
HBIOHarvard Bioscience Inc
Released Oct 25, 2018, after the close
10-Q filed Nov 1, 2018, 32 days after period end · 0001171843-18-007483
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Revenue | $28.64M | $18.72M | $25.01M | $25.73M |
| Net Income | -$256.00K | -$417.00K | -$1.64M | -$847.00K |
| EPS Diluted |
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.01 |
| -$0.05 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
